Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 153.27
-0.013 %
$ 15.5 B
Market Cap
40.87
P/E
NBIX - COST OF REVENUE
Cost of Revenue NBIX - Neurocrine Biosciences, Inc.
39.7 M
LAST VALUE
66.62%
2 YEAR CAGR
52.02%
5 YEAR CAGR
11.15%
10 YEAR CAGR